Biotech Values

[poorgradstudent]

You know me... I'm always skeptical when companies do not release the results of formal analyses. I like to make up my own mind after seeing the data rather than being coached.

If Dr. Gold considered it worthwhile enough to tell investors and doctors that 9902A was tracking similar to 9901, then it should be worthwhile enough to give investors and doctors the data. Plus, as a bit of a purist, I think it goes against the concept of scientific meetings to present some data while holding back other data.